458 related articles for article (PubMed ID: 20375786)
1. Pulmonary aspergillosis: clinical presentation, diagnostic tests, management and complications.
Sherif R; Segal BH
Curr Opin Pulm Med; 2010 May; 16(3):242-50. PubMed ID: 20375786
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary aspergillosis: recent advances.
Thompson GR; Patterson TF
Semin Respir Crit Care Med; 2011 Dec; 32(6):673-81. PubMed ID: 22167395
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of voriconazole against invasive pulmonary aspergillosis in a guinea-pig model.
Chandrasekar PH; Cutright J; Manavathu E
J Antimicrob Chemother; 2000 May; 45(5):673-6. PubMed ID: 10797091
[TBL] [Abstract][Full Text] [Related]
4. [Aspergillosis. Clinical forms and treatment].
Fortún J; Meije Y; Fresco G; Moreno S
Enferm Infecc Microbiol Clin; 2012 Apr; 30(4):201-8. PubMed ID: 22341751
[TBL] [Abstract][Full Text] [Related]
5. Nebulised liposomal amphotericin B for Aspergillus lung diseases: case series and literature review.
Godet C; Goudet V; Laurent F; Le Moal G; Gounant V; Frat JP; Cateau E; Roblot F; Cadranel J
Mycoses; 2015 Mar; 58(3):173-80. PubMed ID: 25690951
[TBL] [Abstract][Full Text] [Related]
6. Allergic aspergillosis of the respiratory tract.
Shah A; Panjabi C
Eur Respir Rev; 2014 Mar; 23(131):8-29. PubMed ID: 24591658
[No Abstract] [Full Text] [Related]
7. [Experience with voriconazole in invasive aspergillosis].
Thiel E; Schwartz S
Mycoses; 2003; 46 Suppl 2():3-7. PubMed ID: 15055137
[TBL] [Abstract][Full Text] [Related]
8. Current approaches to diagnosis and treatment of invasive aspergillosis.
Segal BH; Walsh TJ
Am J Respir Crit Care Med; 2006 Apr; 173(7):707-17. PubMed ID: 16387806
[TBL] [Abstract][Full Text] [Related]
9. Activity of voriconazole (UK-109,496) against clinical isolates of Aspergillus species and its effectiveness in an experimental model of invasive pulmonary aspergillosis.
Murphy M; Bernard EM; Ishimaru T; Armstrong D
Antimicrob Agents Chemother; 1997 Mar; 41(3):696-8. PubMed ID: 9056016
[TBL] [Abstract][Full Text] [Related]
10. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis.
Herbrecht R; Denning DW; Patterson TF; Bennett JE; Greene RE; Oestmann JW; Kern WV; Marr KA; Ribaud P; Lortholary O; Sylvester R; Rubin RH; Wingard JR; Stark P; Durand C; Caillot D; Thiel E; Chandrasekar PH; Hodges MR; Schlamm HT; Troke PF; de Pauw B;
N Engl J Med; 2002 Aug; 347(6):408-15. PubMed ID: 12167683
[TBL] [Abstract][Full Text] [Related]
11. New therapies for fungal pneumonia.
Maertens J; Meersseman W; Van Bleyenbergh P
Curr Opin Infect Dis; 2009 Apr; 22(2):183-90. PubMed ID: 19276884
[TBL] [Abstract][Full Text] [Related]
12. Successful treatment of pulmonary invasive aspergillosis with voriconazole in patients who failed conventional therapy.
Garbino J; Rohner P; Kolarova L; Ondrusova A; Lew D
Infection; 2003 Aug; 31(4):241-3. PubMed ID: 14562948
[TBL] [Abstract][Full Text] [Related]
13. Strategy of following voriconazole versus amphotericin B therapy with other licensed antifungal therapy for primary treatment of invasive aspergillosis: impact of other therapies on outcome.
Patterson TF; Boucher HW; Herbrecht R; Denning DW; Lortholary O; Ribaud P; Rubin RH; Wingard JR; DePauw B; Schlamm HT; Troke P; Bennett JE; ;
Clin Infect Dis; 2005 Nov; 41(10):1448-52. PubMed ID: 16231256
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology of invasive aspergillosis and risk factors in non neutropaenic patients.
Gangneux JP; Camus C; Philippe B
Rev Mal Respir; 2010 Oct; 27(8):e34-46. PubMed ID: 20965392
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of voriconazole in a guinea pig model of disseminated invasive aspergillosis.
Kirkpatrick WR; McAtee RK; Fothergill AW; Rinaldi MG; Patterson TF
Antimicrob Agents Chemother; 2000 Oct; 44(10):2865-8. PubMed ID: 10991875
[TBL] [Abstract][Full Text] [Related]
16. The clinical spectrum of pulmonary aspergillosis.
Kosmidis C; Denning DW
Thorax; 2015 Mar; 70(3):270-7. PubMed ID: 25354514
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary fungal infections.
Silveira F; Paterson DL
Curr Opin Pulm Med; 2005 May; 11(3):242-6. PubMed ID: 15818187
[TBL] [Abstract][Full Text] [Related]
18. COVID-19-Associated Pulmonary Aspergillosis, Fungemia, and Pneumocystosis in the Intensive Care Unit: a Retrospective Multicenter Observational Cohort during the First French Pandemic Wave.
Bretagne S; Sitbon K; Botterel F; Dellière S; Letscher-Bru V; Chouaki T; Bellanger AP; Bonnal C; Fekkar A; Persat F; Costa D; Bourgeois N; Dalle F; Lussac-Sorton F; Paugam A; Cassaing S; Hasseine L; Huguenin A; Guennouni N; Mazars E; Le Gal S; Sasso M; Brun S; Cadot L; Cassagne C; Cateau E; Gangneux JP; Moniot M; Roux AL; Tournus C; Desbois-Nogard N; Le Coustumier A; Moquet O; Alanio A; Dromer F;
Microbiol Spectr; 2021 Oct; 9(2):e0113821. PubMed ID: 34668768
[TBL] [Abstract][Full Text] [Related]
19. Discussion of case reports.
Maertens J
Mycoses; 2010 Jul; 53 Suppl 2():16-8. PubMed ID: 20591017
[No Abstract] [Full Text] [Related]
20. Introduction to case reports.
Maertens J
Mycoses; 2010 Jul; 53 Suppl 2():1-2. PubMed ID: 20591010
[No Abstract] [Full Text] [Related]
[Next] [New Search]
